dactinomycin and sorafenib

dactinomycin has been researched along with sorafenib in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, K; Li, Y; Lu, X; Ren, X	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Pappo, A; Paulino, AC	1
Chen, YJ; Hsu, ML; Huang, WP; Huang, YC; Ko, WC; Lee, JJ; Lin, JC; Liu, CL; Liu, TP; Wu, CH	1
Chen, D; Eyupoglu, IY; Savaskan, N	1

Reviews

2 review(s) available for dactinomycin and sorafenib

Article	Year
Small molecule discoidin domain receptor kinase inhibitors and potential medical applications. Journal of medicinal chemistry, 2015, Apr-23, Volume: 58, Issue:8 Topics: Amino Acid Sequence; Animals; Discoidin Domain Receptors; Drug Discovery; Humans; Inflammation; Ligands; Models, Molecular; Molecular Sequence Data; Neoplasms; Protein Conformation; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Small Molecule Libraries	2015
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Article

Year

Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.

Journal of medicinal chemistry, 2015, Apr-23, Volume: 58, Issue:8

Topics: Amino Acid Sequence; Animals; Discoidin Domain Receptors; Drug Discovery; Humans; Inflammation; Ligands; Models, Molecular; Molecular Sequence Data; Neoplasms; Protein Conformation; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Small Molecule Libraries

2015

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for dactinomycin and sorafenib

Article	Year
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine	2009
Sorafenib induces autophagy in human myeloid dendritic cells and prolongs survival of skin allografts. Transplantation, 2013, Mar-27, Volume: 95, Issue:6 Topics: Animals; Antigens; Autophagy; Cell Survival; Dactinomycin; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Mice; Microscopy, Fluorescence; Myeloid Cells; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Skin Transplantation; Sorafenib; Transplantation, Homologous	2013
Ferroptosis and Cell Death Analysis by Flow Cytometry. Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1601 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dactinomycin; Flow Cytometry; Humans; Indicators and Reagents; Iron; Necrosis; Niacinamide; Phenylurea Compounds; Piperazines; Propidium; Rats; Sorafenib	2017